Adherence to Quality Indicators Low in Chronic Myeloid Leukemia
WEDNESDAY, Nov. 23, 2022 -- For newly diagnosed chronic-phase chronic myeloid leukemia (CML) patients, adherence to guideline-based quality indicators is low, according to a study published online Nov. 11 in Leukemia& Lymphoma.
Genevi ève...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Chronic Leukemia | Chronic Myeloid Leukaemia | Leukemia | Lymphoma | Pharmaceuticals | Study